Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Clovis Oncology Stock Price (Quote) NASDAQ:CLVS
$6.17 ( 4.93% ) Wednesday, 23rd Jun 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $4.99 | $7.24 | Wednesday, 23rd Jun 2021 CLVS stock ended at $6.17. This is 4.93% more than the trading day before Tuesday, 22nd Jun 2021. During the day the stock fluctuated 5.42% from a day low at $5.90 to a day high of $6.22. |
| 90 days | $4.99 | $7.35 | |
| 52 weeks | $4.08 | $11.10 |
Historical Clovis Oncology prices
| Date | Open | High | Low | Close | Volume |
| 2021-06-23 | $5.90 | $6.22 | $5.90 | $6.17 | 5 175 281 |
| 2021-06-22 | $5.95 | $6.05 | $5.78 | $5.88 | 4 384 907 |
| 2021-06-21 | $5.98 | $6.01 | $5.76 | $5.96 | 4 315 400 |
| 2021-06-18 | $6.01 | $6.24 | $5.92 | $5.97 | 6 886 494 |
| 2021-06-17 | $5.99 | $6.31 | $5.98 | $6.09 | 10 078 720 |
| 2021-06-16 | $5.79 | $5.92 | $5.58 | $5.91 | 5 835 737 |
| 2021-06-15 | $5.85 | $6.14 | $5.71 | $5.77 | 5 878 804 |
| 2021-06-14 | $5.90 | $6.25 | $5.80 | $5.84 | 9 592 621 |
| 2021-06-11 | $6.00 | $6.02 | $5.66 | $5.78 | 7 186 012 |
| 2021-06-10 | $6.11 | $6.28 | $5.78 | $5.97 | 12 001 599 |
| 2021-06-09 | $7.12 | $7.24 | $6.21 | $6.31 | 45 801 491 |
| 2021-06-08 | $5.57 | $5.83 | $5.50 | $5.71 | 11 054 609 |
| 2021-06-07 | $5.41 | $5.55 | $5.20 | $5.45 | 7 456 939 |
| 2021-06-04 | $5.35 | $5.52 | $5.33 | $5.36 | 3 510 099 |
| 2021-06-03 | $5.60 | $5.82 | $5.36 | $5.37 | 9 344 638 |
| 2021-06-02 | $5.19 | $5.53 | $5.13 | $5.51 | 10 480 550 |
| 2021-06-01 | $5.20 | $5.22 | $5.10 | $5.13 | 2 678 345 |
| 2021-05-28 | $5.22 | $5.29 | $5.11 | $5.13 | 3 427 713 |
| 2021-05-27 | $5.12 | $5.33 | $5.03 | $5.22 | 4 994 623 |
| 2021-05-26 | $5.05 | $5.13 | $5.01 | $5.06 | 3 056 360 |
| 2021-05-25 | $5.05 | $5.18 | $5.02 | $5.02 | 4 183 215 |
| 2021-05-24 | $5.21 | $5.22 | $4.99 | $5.07 | 6 218 972 |
| 2021-05-21 | $5.33 | $5.40 | $5.18 | $5.18 | 3 448 533 |
| 2021-05-20 | $5.35 | $5.50 | $5.21 | $5.28 | 3 577 708 |
| 2021-05-19 | $5.47 | $5.52 | $5.24 | $5.27 | 3 898 149 |
| 2021-05-18 | $5.79 | $5.79 | $5.49 | $5.49 | 4 599 241 |
| 2021-05-17 | $5.80 | $6.05 | $5.75 | $5.87 | 2 169 947 |
| 2021-05-14 | $5.70 | $6.00 | $5.68 | $5.87 | 3 204 756 |
| 2021-05-13 | $5.80 | $5.89 | $5.44 | $5.62 | 3 224 825 |
| 2021-05-12 | $5.45 | $6.07 | $5.45 | $5.71 | 3 832 386 |
| 2021-05-11 | $5.07 | $5.67 | $5.03 | $5.61 | 3 187 985 |
| 2021-05-10 | $5.62 | $5.64 | $5.25 | $5.29 | 5 607 574 |
| 2021-05-07 | $5.73 | $5.92 | $5.60 | $5.64 | 4 512 628 |
| 2021-05-06 | $5.84 | $5.89 | $5.39 | $5.67 | 4 904 128 |
| 2021-05-05 | $5.28 | $6.36 | $5.27 | $5.86 | 12 703 339 |
| 2021-05-04 | $5.75 | $5.75 | $5.45 | $5.51 | 4 693 111 |
| 2021-05-03 | $5.97 | $5.99 | $5.67 | $5.77 | 2 755 188 |
| 2021-04-30 | $5.95 | $6.16 | $5.90 | $5.94 | 2 441 771 |
| 2021-04-29 | $6.23 | $6.24 | $5.95 | $6.02 | 2 355 934 |
| 2021-04-28 | $6.12 | $6.24 | $6.07 | $6.15 | 1 956 360 |
| 2021-04-27 | $6.35 | $6.43 | $6.10 | $6.15 | 2 114 569 |
| 2021-04-26 | $6.13 | $6.43 | $6.05 | $6.29 | 3 162 044 |
| 2021-04-23 | $6.08 | $6.21 | $5.95 | $6.09 | 2 573 287 |
| 2021-04-22 | $6.04 | $6.32 | $5.85 | $6.09 | 4 158 054 |
| 2021-04-21 | $5.67 | $6.03 | $5.56 | $6.00 | 3 497 575 |
| 2021-04-20 | $5.75 | $5.80 | $5.48 | $5.67 | 4 849 425 |
| 2021-04-19 | $5.88 | $6.14 | $5.76 | $5.78 | 3 730 469 |
| 2021-04-16 | $6.06 | $6.13 | $5.90 | $5.98 | 3 297 152 |
| 2021-04-15 | $6.25 | $6.40 | $6.01 | $6.10 | 3 613 594 |
| 2021-04-14 | $6.14 | $6.42 | $6.07 | $6.25 | 3 715 211 |
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates, which include Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is under review with the U.S. and E.U. regulatory authorities for the treatment of non-small cell lung cancer; Rucapar... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
